Dr. Shimizu has over 35 years of corporate experience in ophthalmology. In 1992 his focus transitioned from research to product development. Rob has led cross-functional teams focused on product development of pharmaceuticals (including drug delivery), ocular devices and combination products. These activities developed treatments for diseases in both the anterior and posterior segments of the eye. Rob has led pharmaceutical development, device development, preclinical testing, clinical evaluation and regulatory activities addressing global markets.